Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions

BACKGROUND: Retinal vein occlusion-induced macular edema (RVO-ME) is a significant global cause of vision loss, with the effectiveness of combined anti-vascular endothelial growth factor (anti-VEGF) drugs and dexamethasone implantation (DEX I) being a relevant, yet not thoroughly explored, area of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Fengmei, Gong, Hui, Zhang, Han, Zhang, Xiaoguang, Liu, Xiaolin, Gao, Peifeng, Li, Junying, Zhang, Guisen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268884/
https://www.ncbi.nlm.nih.gov/pubmed/37301978
http://dx.doi.org/10.12659/MSM.939277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268884/
https://www.ncbi.nlm.nih.gov/pubmed/37301978
http://dx.doi.org/10.12659/MSM.939277

Ejemplares similares